Clinical Trial Update: Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision [Phase 4]

View source ↗

Summary

Phase 4 trial update for ranibizumab in macular edema due to branch retinal vein occlusion; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Branch Retinal Vein Occlusion, Macular Edema | Phase 4 | Status: TERMINATED